TOKYO: Japan plans to authorize Thursday the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month. This would make Japan the second country to approve the drug after US regulators authorized it on Friday for emergency use against severe... read full story
"If there is no problem we hope to swiftly approve (the drug) today"
Photo: FILE - This July 9, 2015, file photo shows the headquarters of Gilead Sciences in Foster City, Calif. Federal health officials on Tuesday, June 28, 2016, approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus. The Food and Drug Administration approved the combination pill, Epclusa, from Gilead Sciences for patients with and without liver damage. The new drug's broad indication could make it easier to use than five other hepatitis drugs recently approved by the FDA, which are each tailored to different viral strains or stages of liver disease. (AP Photo/Eric Risberg, File)